Join the club for FREE to access the whole archive and other member benefits.

Experts highlight the potential of xenografts in personalized oncology

31-Jan-2017

Key points from article :

Patient-derived xenografts are tumour samples that are extracted from patients and reimplanted in mice in the same location as in the patient.

Reproduces the behavior of each tumor in a personalized way and enables testing of several treatment alternatives.

EurOPDX consortium integrates 16 European research institutions.

The study was published in the Nature Reviews Cancer journal.

Mentioned in this article:

Click on resource name for more details.

Alberto Villanueva

Oncology Researcher at ICO and Chief of Scientific Office at Xenopat.

Catalan Institute of Oncology (ICO)

Public centre working exclusively in the field of cancer.

Nature Reviews Cancer

Medical journal covering the field of oncology.

Topics mentioned on this page:
Cancer